Follow the Voyageur Pharmaceuticals Ltd. stock price and the full directors' dealings record of the company, a publicly traded company based in Canada. Shares are listed on CA CA, under the oversight of SEDI. Market capitalisation: €22.4m. The latest transaction was disclosed on 9 June 2026 (16 - Acquisition or disposition under a prospectus exemption). Among the most active insiders: McBeth, Kevin Richard. Every trade is accessible without an account.
15
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
41Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
200,000 shares@ CA$0.10100.0% of flowCommon SharesTSXSEDI:4732703
Canonical exit: 3 Sept 2026 (T+90)
15 of 15 declarations
About Voyageur Pharmaceuticals Ltd.
Voyageur Pharmaceuticals Ltd. is a Canadian pharmaceutical company focused on developing health products. It is listed on the Toronto Stock Exchange (XTSE).